Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Natco Pharma
Natco Pharma
Activities:
Pharmaceutical
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
Therapeutic: ensifentrine for chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) comes in various guises, including chronic bronchitis and emphysema; and, although incurable, the symptoms can be managed with...
Merck’s clesrovimab meets all primary endpoints in Phase IIb/III trial for RSV in infants
A teaser of the Phase IIb/III trial released by Merck indicates that clesrovimab can reduce the need to medically attend lower respiratory infections caused by RSV in infants
Bringing biotech to the Baltics: the rise of Lithuania
Lithuania’s biotechnology competencies lie in cell and gene therapies, enzymes and the wider pharmaceutical industry, offering companies a rich pool of talent in a...
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Regulatory
Several large Indian pharma companies under US FDA scrutiny
Recent regulatory action by the FDA on leading Indian firms has affected the country's exports, according to Chairman of Dr. Reddy's Laboratories
Finance
Natco shows there is more to Indian pharma than generics
Company is establishing a solid platform for rapid growth
Regulatory
Natco Pharma wins US patent case against Teva
Ruling by US Court of Appeals is a major relief to the Indian company
Pharmaceutical
Natco Pharma launches generic sofosbuvir in Nepal
Natco becomes the first Indian company to launch the drug after signing a voluntary licence with Gilead Sciences
Regulatory
Intellectual property battles rage on
Spate of cases filed recently shows that patent battles are heating up
You need to be a subscriber to read this article.
Click here
to find out more.
Pharmaceutical
What future for branded drugs in India?
A landmark patent ruling against Novartis by the Supreme Court in India could lead branded drug manufacturers to review their strategies. Asia correspondent A Nair looks at the implications
Subscribe now